Published in Mayo Clin Proc on January 29, 2010
Contributions of antinucleoprotein IgG to heterosubtypic immunity against influenza virus. J Immunol (2011) 1.74
Structural basis of influenza virus neutralization. Ann N Y Acad Sci (2011) 1.37
Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance. J Virol (2011) 1.35
Hallmarks of CD4 T cell immunity against influenza. J Intern Med (2011) 1.19
Residual baculovirus in insect cell-derived influenza virus-like particle preparations enhances immunogenicity. PLoS One (2012) 1.05
Analysis of public responses to preparedness policies: the cases of H1N1 influenza vaccination and gas mask distribution. Isr J Health Policy Res (2013) 0.99
Religion and preventive service use: do congregational support and religious beliefs explain the relationship between attendance and utilization? J Behav Med (2011) 0.85
Protocol for a randomised controlled trial examining the impact of a web-based personally controlled health management system on the uptake of influenza vaccination rates. BMC Health Serv Res (2012) 0.85
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines. J Virol (2010) 0.85
Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design. Front Immunol (2011) 0.85
AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice. Front Immunol (2015) 0.81
Serological survey of the novel influenza A H1N1 in inner city Winnipeg, Manitoba, 2009. Can J Infect Dis Med Microbiol (2012) 0.80
Influenza vaccination among cancer survivors: disparities in prevalence between blacks and whites. J Cancer Surviv (2013) 0.80
Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age. Hum Vaccin Immunother (2013) 0.78
Mallard or chicken? Comparing the isolation of avian influenza A viruses in embryonated Mallard and chicken eggs. Infect Ecol Epidemiol (2015) 0.75
Addition of αGal HyperAcute™ technology to recombinant avian influenza vaccines induces strong low-dose antibody responses. PLoS One (2017) 0.75
From Variation of Influenza Viral Proteins to Vaccine Development. Int J Mol Sci (2017) 0.75
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Evolution and ecology of influenza A viruses. Microbiol Rev (1992) 39.99
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Characterization of the 1918 influenza virus polymerase genes. Nature (2005) 15.73
Mapping the antigenic and genetic evolution of influenza virus. Science (2004) 14.28
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63
The global circulation of seasonal influenza A (H3N2) viruses. Science (2008) 10.05
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA (2000) 8.31
The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79
Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 7.29
Antivirals for influenza in healthy adults: systematic review. Lancet (2006) 7.20
Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med (2000) 6.83
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Live attenuated versus inactivated influenza vaccine in infants and young children. N Engl J Med (2007) 6.54
Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2009) 6.52
Respiratory viruses and exacerbations of asthma in adults. BMJ (1993) 6.37
The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med (1995) 6.16
Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 6.09
Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA (2009) 5.84
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep (2009) 5.80
Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet (2000) 5.77
Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol (1968) 5.69
The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA (1994) 5.29
Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J (2001) 4.93
Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med (2003) 4.86
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
Global transmission of oseltamivir-resistant influenza. N Engl J Med (2009) 4.34
Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol (1998) 4.29
Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med (2007) 4.16
Effectiveness of school-based influenza vaccination. N Engl J Med (2006) 4.06
Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol (2005) 4.04
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA (1990) 3.71
Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA (1999) 3.71
Retraction of an interpretation. Lancet (2004) 3.55
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA (1999) 3.53
Association of serum anti-neuraminidase antibody with resistance to influenza in man. N Engl J Med (1972) 3.51
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep (2009) 3.43
Evolution of the H3 influenza virus hemagglutinin from human and nonhuman hosts. J Virol (1992) 3.37
Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol (1979) 3.36
Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol (1986) 3.33
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis (2009) 3.26
The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J Virol (1998) 3.25
Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev (2007) 3.23
Biologic and immunologic characteristics of cold-adapted influenza virus. J Immunol (1969) 3.17
The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med (2001) 3.16
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis (2009) 3.12
Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA (2007) 3.10
Illness among schoolchildren during influenza season: effect on school absenteeism, parental absenteeism from work, and secondary illness in families. Arch Pediatr Adolesc Med (2002) 3.02
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin. Vaccine (2007) 2.76
Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev (2008) 2.69
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis (1995) 2.67
Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses. Vaccine (2008) 2.56
Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis (1970) 2.53
Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis (2007) 2.36
Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA (2000) 2.35
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J Exp Med (1983) 2.27
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Rhinovirus and influenza type A infections as precipitants of asthma. Am Rev Respir Dis (1976) 2.20
Maternal morbidity and perinatal outcomes among pregnant women with respiratory hospitalizations during influenza season. Am J Obstet Gynecol (2003) 2.09
Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J (2007) 2.07
Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics (2002) 2.03
Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med (2001) 2.03
Cardiovascular manifestations associated with influenza virus infection. Int J Cardiol (2008) 2.01
Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections. Pediatr Infect Dis J (2006) 1.98
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine (2005) 1.97
Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines. Viral Immunol (2002) 1.97
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96
The origin and virulence of the 1918 "Spanish" influenza virus. Proc Am Philos Soc (2006) 1.96
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol (2004) 1.94
Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev (2006) 1.89
Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics (2004) 1.88
Viral infection and renal transplant rejection. Br Med J (1972) 1.87
Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. J Infect Dis (1999) 1.87
Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant (2007) 1.83
Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol (2004) 1.82
Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med (1999) 1.80
An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc (1992) 1.76
Live attenuated or inactivated influenza vaccines and medical encounters for respiratory illnesses among US military personnel. JAMA (2009) 1.74
Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome. Chest (2001) 1.74
A "universal" human influenza A vaccine. Virus Res (2004) 1.73
Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med (1997) 1.73
The role of respiratory viruses in cystic fibrosis. J Cyst Fibros (2008) 1.71
Comparison of the trivalent live attenuated vs. inactivated influenza vaccines among U.S. military service members. Vaccine (2009) 1.70
Influenza among hospitalized adults with leukemia. Clin Infect Dis (1997) 1.68
Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine (2007) 1.66
Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis (2009) 1.64
Understanding those who do not understand: a brief review of the anti-vaccine movement. Vaccine (2001) 1.60
Health care worker beliefs about influenza vaccine and reasons for non-vaccination--a cross-sectional survey. J Clin Nurs (2005) 1.60
Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet (2001) 22.07
Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol (2008) 2.97
A program of anticipatory guidance for the prevention of emergency department visits for ear pain. Arch Pediatr Adolesc Med (2008) 2.36
Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA (2003) 2.15
3' tag digital gene expression profiling of human brain and universal reference RNA using Illumina Genome Analyzer. BMC Genomics (2009) 2.12
Developing the next generation of vaccinologists. Vaccine (2010) 2.07
Population-based prevalence of repeated group A beta-hemolytic streptococcal pharyngitis episodes. Mayo Clin Proc (2006) 2.03
Vaccine immunogenetics: bedside to bench to population. Vaccine (2008) 2.01
Reasons for not vaccinating adolescents: National Immunization Survey of Teens, 2008-2010. Pediatrics (2013) 2.01
Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States. Pediatrics (2002) 1.98
The age-old struggle against the antivaccinationists. N Engl J Med (2011) 1.80
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
2009 H1N1 influenza. Mayo Clin Proc (2009) 1.76
The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol (2004) 1.70
Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis (2009) 1.64
Detection of smallpox virus DNA by LightCycler PCR. J Clin Microbiol (2002) 1.62
Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine (2008) 1.60
Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med (2004) 1.59
Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther (2008) 1.59
Vaccines against avian influenza--a race against time. N Engl J Med (2006) 1.57
Requiring influenza vaccination for health care workers: seven truths we must accept. Vaccine (2005) 1.55
Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. J Infect Dis (2006) 1.54
Influenza vaccination among registered nurses: information receipt, knowledge, and decision-making at an institution with a multifaceted educational program. Infect Control Hosp Epidemiol (2008) 1.50
Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum Genet (2009) 1.46
Assessing participation bias in a population-based study of measles-mumps-rubella vaccine immunity in children and adolescents aged 12-18. Paediatr Perinat Epidemiol (2007) 1.45
Independence of measles-specific humoral and cellular immune responses to vaccination. Hum Immunol (2012) 1.44
If you could halve the mortality rate, would you do it? Clin Infect Dis (2002) 1.42
Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine. Pediatrics (2008) 1.41
The association of CD46, SLAM and CD209 cellular receptor gene SNPs with variations in measles vaccine-induced immune responses: a replication study and examination of novel polymorphisms. Hum Hered (2011) 1.40
Confronting bioterrorism: physicians on the front line. Mayo Clin Proc (2002) 1.40
Asthma and the immune response to MMR vaccine viruses in Somali immigrant children: a cross-sectional retrospective cohort study. Prim Care Respir J (2013) 1.40
Revised SHEA position paper: influenza vaccination of healthcare personnel. Infect Control Hosp Epidemiol (2010) 1.39
Gender effects on humoral immune responses to smallpox vaccine. Vaccine (2009) 1.39
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection. Vaccine (2011) 1.39
Adolescent Vaccination Performance in South Carolina Compared to the United States. J S C Med Assoc (2016) 1.39
Methodologic reporting requirements for clinical trials: advancing the science today and tomorrow. Vaccine (2011) 1.37
Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis (2006) 1.35
Immunization and the prevention of influenza and pneumococcal disease in people with diabetes. Diabetes Care (2003) 1.35
Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis (2005) 1.35
Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination. J Infect Dis (2010) 1.31
Application of pharmacogenomics to vaccines. Pharmacogenomics (2009) 1.30
2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine. Hum Immunol (2010) 1.30
HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics (2005) 1.28
Immunogenetics of seasonal influenza vaccine response. Vaccine (2008) 1.25
Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine (2011) 1.24
Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol (2007) 1.24
Genome-wide association study of antibody response to smallpox vaccine. Vaccine (2012) 1.23
Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2009) 1.22
Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol (2008) 1.21
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS (2011) 1.21
Calculating sample size estimates for RNA sequencing data. J Comput Biol (2013) 1.21
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine (2011) 1.18
Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine. J Infect Dis (2011) 1.18
Systems biology approaches to new vaccine development. Curr Opin Immunol (2011) 1.17
The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet (2011) 1.17
Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations. Vaccine (2009) 1.17
The clinician's guide to the anti-vaccinationists' galaxy. Hum Immunol (2012) 1.17
Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol (2010) 1.16
Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients. Hum Genet (2012) 1.15
SNP/haplotype associations in cytokine and cytokine receptor genes and immunity to rubella vaccine. Immunogenetics (2010) 1.15
Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics (2005) 1.13
Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine (2011) 1.12
Avian and pandemic influenza: an overview. Vaccine (2007) 1.12
Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr Infect Dis J (2009) 1.11
Influenza and pneumococcal immunization in diabetes. Diabetes Care (2004) 1.11
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin Immunol (2013) 1.11
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination. Vaccine (2009) 1.10
Frequency of measles virus-specific CD4+ and CD8+ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol (2003) 1.10
HLA supertypes and immune responses to measles-mumps-rubella viral vaccine: findings and implications for vaccine design. Vaccine (2007) 1.10